http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#Head http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#assertion http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#provenance http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#pubinfo http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#assertion http://purl.obolibrary.org/obo/DOID_0060318 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0060318 http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00755 http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association http://www.w3.org/2000/01/rdf-schema#label tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia apl french american british fab classification m3 including the m3 variant characterized by the presence of the t 15 17 translocation and or the presence of the pml rari gene who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline based chemotherapy is contraindicated tretinoin capsules are for the induction of remission only the optimal consolidation or maintenance regimens have not been defined but all patients should receive an accepted form of remission consolidation and or maintenance therapy for apl after completion of induction therapy with tretinoin capsules http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00755 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#provenance http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#pubinfo http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#sig http://purl.org/nanopub/x/hasSignature Ez+ST6P2RgmtI+Jl9MRmQglECNFciLbcNe9fxg4alaeJjPYXA+QPmIVY+zdT3zyewEOLvF4xFhMz+7wK7xAsU9La9qSscuarl46oIDltC0DMmUrE2aSY0T6qx9rYEsfmVdmpSkI7ZLamCxQyJwbE9lqbQaigUtak20+1//63SRQ= http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://purl.org/dc/terms/created 2021-06-12T16:32:41.896+02:00 http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAoMvSloXnVwg48KXkUWn_gb5depyi_b9CiNQZ-4Z4N_U https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs